- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Mouse CD20 Antibody / Mouse MS4A1 Polyclonal Antibody targets CD20, a membrane-associated phosphoprotein encoded by the Ms4a1 gene. CD20 belongs to the membrane-spanning 4A protein family and is expressed predominantly during B-cell development, beginning at the late precursor stage and continuing through mature B lymphocytes. Its expression generally declines during terminal differentiation into antibody-secreting plasma cells. This characteristic distribution makes CD20 an important marker for investigating B-cell populations, lymphoid tissue organization, and immune system development.
CD20 is a nonglycosylated protein containing four transmembrane domains, intracellular N- and C-terminal regions, and two extracellular loops. Its larger extracellular loop contains epitopes recognized by several therapeutic monoclonal antibodies. CD20 lacks intrinsic enzymatic activity and has no firmly established physiological ligand. Instead, it contributes to membrane-associated signaling processes that influence B-cell activation, calcium regulation, and interactions between signaling proteins at the cell surface.
Research has linked CD20 to intracellular calcium homeostasis and signaling downstream of the B-cell antigen receptor. CD20 may influence calcium responses following antigen stimulation, contributing to the regulation of lymphocyte activation and differentiation. Its organization within the plasma membrane and interactions with neighboring proteins help coordinate signaling events associated with immune responses. Although the precise physiological functions of CD20 remain incompletely understood, studies of CD20 deficiency and altered expression have provided insight into its contributions to B-cell signaling and antibody-mediated immunity.
CD20 expression is particularly relevant to the organization of secondary lymphoid tissues, where B lymphocytes participate in antigen recognition, clonal expansion, and the development of humoral immune responses. Within lymphoid follicles, B-cell populations undergo activation and differentiation in response to antigenic stimulation. Changes in CD20 abundance can accompany alterations in B-cell maturation and cellular identity. CD20 is also extensively investigated in B-cell malignancies and autoimmune disorders because its restricted expression makes it an important target for therapeutic B-cell depletion.
Mouse CD20 Antibody supports investigations into CD20 expression and its relationship to B-cell development, immune signaling, and lymphoid tissue organization. Understanding how CD20 abundance and membrane distribution change during immune activation may help clarify mechanisms governing B-cell responses, inflammatory disease, and the effects of CD20-directed therapeutic strategies.
For additional CD20 research, explore our CD20 Antibody rIGEL/773, a recombinant monoclonal antibody supported by Western blot, immunohistochemistry, immunofluorescence, flow cytometry, and human protein microarray data.
Optimal dilution of the Mouse CD20 Antibody / Mouse MS4A1 Polyclonal Antibody should be determined by the researcher.
Recombinant mouse protein (amino acids M1-P291) was used as the immunogen for the Mouse CD20 Antibody.
After reconstitution, the Mouse CD20 Antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
B-lymphocyte antigen CD20 antibody, B-cell surface antigen B1 antibody, B1 antigen antibody, Membrane-spanning 4-domains subfamily A member 1 antibody, MS4A1 antibody, CD20 antigen antibody, CD20 molecule antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.